The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Tuberculosis Diagnostics and Treatment-Global Market Insights and Sales Trends 2025
Synopsis
The global Tuberculosis Diagnostics and Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Tuberculosis Diagnostics and Treatment in various end use industries. The expanding demands from the Hospital, Clinic and Other,, are propelling Tuberculosis Diagnostics and Treatment market. Skin Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Laboratory Testing segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Tuberculosis Diagnostics and Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Tuberculosis Diagnostics and Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Tuberculosis Diagnostics and Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Tuberculosis Diagnostics and Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Tuberculosis Diagnostics and Treatment covered in this report include Cepheid Inc, Becton Dickinson, Hain LifeSciences, Abbott Laboratories, Alere, Inc, Roche AG, Hologic Corporation, bioMerieux and Sanofi, etc.
The global Tuberculosis Diagnostics and Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cepheid Inc
Becton Dickinson
Hain LifeSciences
Abbott Laboratories
Alere, Inc
Roche AG
Hologic Corporation
bioMerieux
Sanofi
QIAGEN
Akonni Biosystems, Inc.
Epistem Holdings Plc
Gen-Probe Inc.
EIKEN Chemical
Thermo Fisher Scientific, Inc
Global Tuberculosis Diagnostics and Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tuberculosis Diagnostics and Treatment market, Segment by Type:
Skin Testing
Laboratory Testing
Global Tuberculosis Diagnostics and Treatment market, by Application
Hospital
Clinic
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Tuberculosis Diagnostics and Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Tuberculosis Diagnostics and Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Tuberculosis Diagnostics and Treatment in various end use industries. The expanding demands from the Hospital, Clinic and Other,, are propelling Tuberculosis Diagnostics and Treatment market. Skin Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Laboratory Testing segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Tuberculosis Diagnostics and Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Tuberculosis Diagnostics and Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Tuberculosis Diagnostics and Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Tuberculosis Diagnostics and Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Tuberculosis Diagnostics and Treatment covered in this report include Cepheid Inc, Becton Dickinson, Hain LifeSciences, Abbott Laboratories, Alere, Inc, Roche AG, Hologic Corporation, bioMerieux and Sanofi, etc.
The global Tuberculosis Diagnostics and Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cepheid Inc
Becton Dickinson
Hain LifeSciences
Abbott Laboratories
Alere, Inc
Roche AG
Hologic Corporation
bioMerieux
Sanofi
QIAGEN
Akonni Biosystems, Inc.
Epistem Holdings Plc
Gen-Probe Inc.
EIKEN Chemical
Thermo Fisher Scientific, Inc
Global Tuberculosis Diagnostics and Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tuberculosis Diagnostics and Treatment market, Segment by Type:
Skin Testing
Laboratory Testing
Global Tuberculosis Diagnostics and Treatment market, by Application
Hospital
Clinic
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Tuberculosis Diagnostics and Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Tuberculosis Diagnostics and Treatment
1.1 Tuberculosis Diagnostics and Treatment Market Overview
1.1.1 Tuberculosis Diagnostics and Treatment Product Scope
1.1.2 Tuberculosis Diagnostics and Treatment Market Status and Outlook
1.2 Global Tuberculosis Diagnostics and Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Tuberculosis Diagnostics and Treatment Market Size by Region (2018-2029)
1.4 Global Tuberculosis Diagnostics and Treatment Historic Market Size by Region (2018-2023)
1.5 Global Tuberculosis Diagnostics and Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Tuberculosis Diagnostics and Treatment Market Size (2018-2029)
1.6.1 North America Tuberculosis Diagnostics and Treatment Market Size (2018-2029)
1.6.2 Europe Tuberculosis Diagnostics and Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size (2018-2029)
1.6.4 Latin America Tuberculosis Diagnostics and Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size (2018-2029)
2 Tuberculosis Diagnostics and Treatment Market by Type
2.1 Introduction
2.1.1 Skin Testing
2.1.2 Laboratory Testing
2.2 Global Tuberculosis Diagnostics and Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Tuberculosis Diagnostics and Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Tuberculosis Diagnostics and Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Tuberculosis Diagnostics and Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Tuberculosis Diagnostics and Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Tuberculosis Diagnostics and Treatment Revenue Breakdown by Type (2018-2029)
3 Tuberculosis Diagnostics and Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Other
3.2 Global Tuberculosis Diagnostics and Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Tuberculosis Diagnostics and Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Tuberculosis Diagnostics and Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Tuberculosis Diagnostics and Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Tuberculosis Diagnostics and Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Tuberculosis Diagnostics and Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Tuberculosis Diagnostics and Treatment Revenue Breakdown by Application (2018-2029)
4 Tuberculosis Diagnostics and Treatment Competition Analysis by Players
4.1 Global Tuberculosis Diagnostics and Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tuberculosis Diagnostics and Treatment as of 2022)
4.3 Date of Key Players Enter into Tuberculosis Diagnostics and Treatment Market
4.4 Global Top Players Tuberculosis Diagnostics and Treatment Headquarters and Area Served
4.5 Key Players Tuberculosis Diagnostics and Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Tuberculosis Diagnostics and Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Cepheid Inc
5.1.1 Cepheid Inc Profile
5.1.2 Cepheid Inc Main Business
5.1.3 Cepheid Inc Tuberculosis Diagnostics and Treatment Products, Services and Solutions
5.1.4 Cepheid Inc Tuberculosis Diagnostics and Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Cepheid Inc Recent Developments
5.2 Becton Dickinson
5.2.1 Becton Dickinson Profile
5.2.2 Becton Dickinson Main Business
5.2.3 Becton Dickinson Tuberculosis Diagnostics and Treatment Products, Services and Solutions
5.2.4 Becton Dickinson Tuberculosis Diagnostics and Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Becton Dickinson Recent Developments
5.3 Hain LifeSciences
5.3.1 Hain LifeSciences Profile
5.3.2 Hain LifeSciences Main Business
5.3.3 Hain LifeSciences Tuberculosis Diagnostics and Treatment Products, Services and Solutions
5.3.4 Hain LifeSciences Tuberculosis Diagnostics and Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Abbott Laboratories Recent Developments
5.4 Abbott Laboratories
5.4.1 Abbott Laboratories Profile
5.4.2 Abbott Laboratories Main Business
5.4.3 Abbott Laboratories Tuberculosis Diagnostics and Treatment Products, Services and Solutions
5.4.4 Abbott Laboratories Tuberculosis Diagnostics and Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Abbott Laboratories Recent Developments
5.5 Alere, Inc
5.5.1 Alere, Inc Profile
5.5.2 Alere, Inc Main Business
5.5.3 Alere, Inc Tuberculosis Diagnostics and Treatment Products, Services and Solutions
5.5.4 Alere, Inc Tuberculosis Diagnostics and Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Alere, Inc Recent Developments
5.6 Roche AG
5.6.1 Roche AG Profile
5.6.2 Roche AG Main Business
5.6.3 Roche AG Tuberculosis Diagnostics and Treatment Products, Services and Solutions
5.6.4 Roche AG Tuberculosis Diagnostics and Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Roche AG Recent Developments
5.7 Hologic Corporation
5.7.1 Hologic Corporation Profile
5.7.2 Hologic Corporation Main Business
5.7.3 Hologic Corporation Tuberculosis Diagnostics and Treatment Products, Services and Solutions
5.7.4 Hologic Corporation Tuberculosis Diagnostics and Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Hologic Corporation Recent Developments
5.8 bioMerieux
5.8.1 bioMerieux Profile
5.8.2 bioMerieux Main Business
5.8.3 bioMerieux Tuberculosis Diagnostics and Treatment Products, Services and Solutions
5.8.4 bioMerieux Tuberculosis Diagnostics and Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 bioMerieux Recent Developments
5.9 Sanofi
5.9.1 Sanofi Profile
5.9.2 Sanofi Main Business
5.9.3 Sanofi Tuberculosis Diagnostics and Treatment Products, Services and Solutions
5.9.4 Sanofi Tuberculosis Diagnostics and Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Sanofi Recent Developments
5.10 QIAGEN
5.10.1 QIAGEN Profile
5.10.2 QIAGEN Main Business
5.10.3 QIAGEN Tuberculosis Diagnostics and Treatment Products, Services and Solutions
5.10.4 QIAGEN Tuberculosis Diagnostics and Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 QIAGEN Recent Developments
5.11 Akonni Biosystems, Inc.
5.11.1 Akonni Biosystems, Inc. Profile
5.11.2 Akonni Biosystems, Inc. Main Business
5.11.3 Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Products, Services and Solutions
5.11.4 Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Revenue (US$ Million) & (2018-2023)
5.11.5 Akonni Biosystems, Inc. Recent Developments
5.12 Epistem Holdings Plc
5.12.1 Epistem Holdings Plc Profile
5.12.2 Epistem Holdings Plc Main Business
5.12.3 Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Products, Services and Solutions
5.12.4 Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Revenue (US$ Million) & (2018-2023)
5.12.5 Epistem Holdings Plc Recent Developments
5.13 Gen-Probe Inc.
5.13.1 Gen-Probe Inc. Profile
5.13.2 Gen-Probe Inc. Main Business
5.13.3 Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Products, Services and Solutions
5.13.4 Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Revenue (US$ Million) & (2018-2023)
5.13.5 Gen-Probe Inc. Recent Developments
5.14 EIKEN Chemical
5.14.1 EIKEN Chemical Profile
5.14.2 EIKEN Chemical Main Business
5.14.3 EIKEN Chemical Tuberculosis Diagnostics and Treatment Products, Services and Solutions
5.14.4 EIKEN Chemical Tuberculosis Diagnostics and Treatment Revenue (US$ Million) & (2018-2023)
5.14.5 EIKEN Chemical Recent Developments
5.15 Thermo Fisher Scientific, Inc
5.15.1 Thermo Fisher Scientific, Inc Profile
5.15.2 Thermo Fisher Scientific, Inc Main Business
5.15.3 Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Products, Services and Solutions
5.15.4 Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Revenue (US$ Million) & (2018-2023)
5.15.5 Thermo Fisher Scientific, Inc Recent Developments
6 North America
6.1 North America Tuberculosis Diagnostics and Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Tuberculosis Diagnostics and Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Tuberculosis Diagnostics and Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Tuberculosis Diagnostics and Treatment Market Dynamics
11.1 Tuberculosis Diagnostics and Treatment Industry Trends
11.2 Tuberculosis Diagnostics and Treatment Market Drivers
11.3 Tuberculosis Diagnostics and Treatment Market Challenges
11.4 Tuberculosis Diagnostics and Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Industrial Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
